Celcuity (CELC) Assets Average (2017 - 2025)
Celcuity (CELC) reported Assets Average of $471.3 million for Q4 2025, up 81.91% on a YoY basis from $259.1 million in Q4 2024, and up 42.9% quarter-over-quarter from $329.8 million in Q3 2025.
Celcuity (CELC) Assets Average (2017 - 2025) Analysis & Trends
Celcuity has reported Assets Average for 9 years, with the latest figure at $471.3 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 81.91% year-over-year to $471.3 million; the trailing twelve-month figure through Dec 2025 stood at $471.3 million (up 81.91% YoY), and the FY2025 full-year result was $355.8 million, up 63.1% from the prior year.
- Assets Average for Q4 2025 stood at $471.3 million, up from $329.8 million in the prior quarter.
- The five-year high for Assets Average was $471.3 million in Q4 2025, with the low at $24.7 million in Q1 2021.
- Historically, Assets Average has averaged $170.9 million across 5 years, with a median of $163.0 million in 2023.
- Annual changes were most pronounced in 2021 — Assets Average soared 537.74% — and 2025, when it dropped 16.43%.
- Celcuity's Assets Average stood at $88.9 million in 2021, then soared by 35.58% to $120.5 million in 2022, then jumped by 38.43% to $166.8 million in 2023, then surged by 55.32% to $259.1 million in 2024, then surged by 81.91% to $471.3 million in 2025.
- The last three Assets Average figures came in at $471.3 million (Q4 2025), $329.8 million (Q3 2025), and $200.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 660.38 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 471.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 471.28 Mn |
| Sep 30, 2025 | 329.80 Mn |
| Jun 30, 2025 | 200.86 Mn |
| Mar 31, 2025 | 231.63 Mn |
| Dec 31, 2024 | 259.08 Mn |
| Sep 30, 2024 | 282.79 Mn |
| Jun 30, 2024 | 240.36 Mn |
| Mar 31, 2024 | 189.70 Mn |
| Dec 31, 2023 | 166.80 Mn |
| Sep 30, 2023 | 147.95 Mn |
| Jun 30, 2023 | 159.20 Mn |
| Mar 31, 2023 | 170.29 Mn |
| Dec 31, 2022 | 120.49 Mn |
| Sep 30, 2022 | 68.82 Mn |
| Jun 30, 2022 | 76.14 Mn |
| Mar 31, 2022 | 82.92 Mn |
| Dec 31, 2021 | 88.87 Mn |
| Sep 30, 2021 | 67.32 Mn |
| Jun 30, 2021 | 39.59 Mn |
| Mar 31, 2021 | 24.66 Mn |